» Articles » PMID: 16670929

Normocalcemic Primary Hyperparathyroidism in Patients with Recurrent Kidney Stones: Pathological Analysis of Parathyroid Glands

Overview
Journal Virchows Arch
Date 2006 May 4
PMID 16670929
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The lack of overt elevation of serum calcium concentration in some patients suffering from primary hyperparathyroidism is an intriguing clinical phenomenon. Previous studies have substantiated abnormal parathyroid tissue in these patients, but the extent and mode of derangements remained largely undefined. The parathyroid tissues from patients of normocalcemic primary hyperparathyroidism (NCPHPT) and those having normal parathyroid glands, hypercalcemic primary hyperplasia, secondary hyperplasia, and adenoma were compared by undertaking quantitative immunohistochemistry analysis on tissue microarray. The statistic results suggested that the parathyroid tissue of NCPHPT approximates more to normal gland than to its counterpart in other groups of parathyroid proliferative diseases in terms of the lack of significant alterations of calcium-sensing receptor (CaSR), chromogranin A (CGA), parathyroid hormone (PTH), and proliferation index (Ki67). On the other hand, the depressed vitamin D receptor (VitDR) and elevated cyclin D1 (CyD1) of NCPHPT indicated the inherent functional abnormalities in parathyroid cells. Our results imply that inherent functional disengagement may exist between CaSR and CyD1 or between CaSR and VitDR or both in parathyroid cells of symptomatic NCPHPT. Lack of enhanced release of CGA and PTH and discordance between proliferative activity and CyD1 expression in parathyroid cells may further hinder the development of hypercalcemia.

Citing Articles

Current opinions on nephrolithiasis associated with primary hyperparathyroidism.

Cong X, Shen L, Gu X Urolithiasis. 2018; 46(5):453-457.

PMID: 29350243 DOI: 10.1007/s00240-018-1038-x.

References
1.
Garfia B, Canadillas S, Canalejo A, Luque F, Siendones E, Quesada M . Regulation of parathyroid vitamin D receptor expression by extracellular calcium. J Am Soc Nephrol. 2002; 13(12):2945-52. DOI: 10.1097/01.asn.0000037676.54018.cb. View

2.
Kifor O, Moore Jr F, Wang P, Goldstein M, Vassilev P, KIFOR I . Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab. 1996; 81(4):1598-606. DOI: 10.1210/jcem.81.4.8636374. View

3.
Gardin J, Paillard M . Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium. Miner Electrolyte Metab. 1984; 10(5):301-8. View

4.
Schmid K, HITTMAIR A, Ladurner D, Sandbichler P, Gasser R, Totsch M . Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study. Virchows Arch A Pathol Anat Histopathol. 1991; 418(4):295-9. DOI: 10.1007/BF01600157. View

5.
Canaff L, Hendy G . Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem. 2002; 277(33):30337-50. DOI: 10.1074/jbc.M201804200. View